Stock Price
2.40
Daily Change
-0.12 -4.58%
Monthly
19.75%
Yearly
80.08%
Q2 Forecast
2.56

Cerus reported $34.78M in Operating Expenses for its fiscal quarter ending in December of 2024.





Operating Expenses Change Date
Cerus USD 34.78M 2.98M Dec/2024
GRIFOLS EUR 1.45B 255.28M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 76.12M 7.38M Mar/2026
Terumo JPY 252.74B 22.88B Dec/2025
Utah Medical Products USD 6.6M 354K Dec/2025